Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2015/150 of 30 January 2015 amending the Annex to Regulation (EU) No 37/2010 as regards the substance ‘gamithromycin’ Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 April 2015.
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Gamithromycin Gamithromycin Porcine 100 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics’ 100 μg/kg Skin and fat in natural proportions 100 μg/kg Liver 300 μg/kg Kidney Bovine 20 μg/kg Fat Not for use in animals producing milk for human consumption. 200 μg/kg Liver 100 μg/kg Kidney
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.